I have three Thorne products in my cabinet. Here is what the P&G Thorne acquisition actually changes, based on the brands bought before it.
The FDA’s compounding committee voted on seven peptides, recommending BPC-157. What peptides are, why the market exploded, and what the vote does and does not decide.
I lift, track my labs, and read the studies. I still ended up with a cabinet full of maybes, while my wife just buys the one gummy she likes at Target. So I stopped asking which ones work and started asking who got paid when I bought them. I cleaned out my medicine cabinet last
BPC-157 promises what an aging body wants most: faster healing, less pain, a return to the version of you that bounced back. It has almost no human evidence behind it. People are sure it works anyway, and in July an FDA committee votes on whether to let pharmacies make it.
The drugs were ordinary. The result wasn’t: a 27-point blood-pressure drop in men medicine usually fails to reach. A colleague mentioned this interesting hypertension treatment project to me almost in passing, so I looked up the study. A group in Los Angeles turned Black barbershops into blood pressure clinics. Men came in for haircuts and,
You order a prescription online and it arrives in days. Some of it is real care. Some is a sales funnel in a white coat. Here is how to tell the difference.
The CVS Caremark deal just moved a trillion-dollar stock. Here is how Americans actually get Zepbound and Mounjaro across the five channels, who really decides, and what each one costs in 2026.
If you have Medicare and your doctor has been telling you about a new daily pill for weight loss, this post is for you. Foundayo is real, it’s FDA-approved, and starting July 1, 2026, it’s covered for $50 a month under Medicare’s GLP-1 Bridge program for eligible beneficiaries. This is genuinely new. Foundayo got FDA
Updated July 1, 2026 · Now live The Medicare GLP-1 Bridge is live as of today. Prior authorizations can be filed starting now (they could not be submitted before July 1). If your copay is still showing the old price at the pharmacy, that is almost always a prior-auth or KwikPen-formulation issue, not a coverage
